Search

Displaying results 6961 - 6970 of 9313 in total
  1. Drug

    Mevociclib

    go.drugbank.com/drugs/DB21454
    Investigational

    The usage of the INN stem '-ciclib' in the name indicates that Mevociclib is a cyclin dependant kinase inhibitor.

  2. Drug

    Risvodetinib

    go.drugbank.com/drugs/DB21602
    Investigational

    The usage of the INN stem '-tinib' in the name indicates that Risvodetinib is a tyrosine kinase inhibitor.

  3. Drug

    NBI-6024

    go.drugbank.com/drugs/DB05819
    Investigational

    NBI-6024 is an altered peptide ligand that is designed to cause an immune response which result in preservation of beta-cell function and endogenous insulin production.

  4. Drug

    Olomorasib

    go.drugbank.com/drugs/DB21697
    Investigational

    The usage of the INN stem '-rasib' in the name indicates that Olomorasib is a Ras protein inhibitor.

  5. Drug

    Istisociclib

    go.drugbank.com/drugs/DB21703
    Investigational

    The usage of the INN stem '-ciclib' in the name indicates that Istisociclib is a cyclin dependant kinase inhibitor.

  6. Drug

    Atirmociclib

    go.drugbank.com/drugs/DB21733
    Investigational

    The usage of the INN stem '-ciclib' in the name indicates that Atirmociclib is a cyclin dependant kinase inhibitor.

  7. Drug

    Propidium

    go.drugbank.com/drugs/DB02166
    Experimental

    Quaternary ammonium analog of ethidium; an intercalating dye with a specific affinity to certain forms of DNA and, used as diiodide, to separate them in density gradients; also forms fluorescent complexes

  8. Drug

    Velsecorat

    go.drugbank.com/drugs/DB16347
    Investigational

    With Mild to Moderate Asthma). … Velsecorat is under investigation in clinical trial NCT02479412 (A Multiple Dosing (14 Days) Study to Assess Efficacy and Safety of Three Dose Levels of AZD7594, Given Once Daily by Inhalation, in Patients

  9. Drug

    Sulfaisodimidine

    go.drugbank.com/drugs/DB13283
    Experimental

    Sulfaisodimidine also called sulfisomidine is an antibacterial product that has been studied for the treatment of urinary tract infections in the 1950s, however, it is unclear whether this drug has been

  10. Drug

    Biropepimut-S

    go.drugbank.com/drugs/DB14816
    Investigational

    Biropepimut-S is under investigation in clinical trial NCT02873819 (Safety and Efficacy Study of GL-0817 (With Cyclophosphamide) for the Prevention of Recurrence of Squamous Cell Carcinoma of the Oral